Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID P22607 2261 FGFR3 JTK4 Craniosynostosis Phosphorylation N S408 P22607 2261 FGFR3 JTK4 Sarcoma Phosphorylation N S408 P22607 2261 FGFR3 JTK4 Craniosynostosis Phosphorylation N T410 P22607 2261 FGFR3 JTK4 Sarcoma Phosphorylation N T410 P22607 2261 FGFR3 JTK4 Craniosynostosis Ubiquitination N K413 P22607 2261 FGFR3 JTK4 Sarcoma Ubiquitination N K413 P22607 2261 FGFR3 JTK4 Uterine corpus endometrial carcinoma Phosphorylation C S424 P22607 2261 FGFR3 JTK4 Craniosynostosis Phosphorylation N S444 P22607 2261 FGFR3 JTK4 Skin cancer Phosphorylation N S444 P22607 2261 FGFR3 JTK4 Transitional cell carcinoma Phosphorylation N S444 P22607 2261 FGFR3 JTK4 Craniosynostosis Phosphorylation N S445 P22607 2261 FGFR3 JTK4 Transitional cell carcinoma Phosphorylation N S445 P22607 2261 FGFR3 JTK4 Craniosynostosis Phosphorylation N T450 P22607 2261 FGFR3 JTK4 Craniosynostosis Phosphorylation N Y577 P22607 2261 FGFR3 JTK4 Skin cutaneous melanoma Phosphorylation N Y577 P22607 2261 FGFR3 JTK4 Craniosynostosis Phosphorylation N S578 P22607 2261 FGFR3 JTK4 Skin cutaneous melanoma Phosphorylation N S578 P22607 2261 FGFR3 JTK4 Glioblastoma multiforme Phosphorylation N Y599 P22607 2261 FGFR3 JTK4 Anophthalmia and microphthalmia Ubiquitination N K632 P22607 2261 FGFR3 JTK4 Kidney renal clear cell carcinoma Ubiquitination N K632 P22607 2261 FGFR3 JTK4 Achondroplasia Phosphorylation N Y647 P22607 2261 FGFR3 JTK4 Bladder cancer Phosphorylation N Y647 P22607 2261 FGFR3 JTK4 Bladder urothelial carcinoma Phosphorylation N Y647 P22607 2261 FGFR3 JTK4 Colon adenocarcinoma Phosphorylation N Y647 P22607 2261 FGFR3 JTK4 Esophageal adenocarcinoma Phosphorylation N Y647 P22607 2261 FGFR3 JTK4 Glioblastoma multiforme Phosphorylation N Y647 P22607 2261 FGFR3 JTK4 Kidney renal papillary cell carcinoma Phosphorylation N Y647 P22607 2261 FGFR3 JTK4 Achondroplasia Phosphorylation N Y648 P22607 2261 FGFR3 JTK4 Bladder cancer Phosphorylation N Y648 P22607 2261 FGFR3 JTK4 Bladder urothelial carcinoma Phosphorylation N Y648 P22607 2261 FGFR3 JTK4 Colon adenocarcinoma Phosphorylation N Y648 P22607 2261 FGFR3 JTK4 Glioblastoma multiforme Phosphorylation N Y648 P22607 2261 FGFR3 JTK4 Kidney renal papillary cell carcinoma Phosphorylation N Y648 P22607 2261 FGFR3 JTK4 Craniosynostosis Phosphorylation N Y724 P22607 2261 FGFR3 JTK4 Inborn genetic diseases Phosphorylation N Y724 P22607 2261 FGFR3 JTK4 Kidney renal papillary cell carcinoma Phosphorylation N Y724 P22607 2261 FGFR3 JTK4 Uterine corpus endometrial carcinoma Phosphorylation N Y724 P22607 2261 FGFR3 JTK4 Craniosynostosis Phosphorylation N Y760 P22607 2261 FGFR3 JTK4 Head and neck squamous cell carcinoma Phosphorylation N Y760 P22607 2261 FGFR3 JTK4 Uterine carcinosarcoma Phosphorylation N Y760 P22607 2261 FGFR3 JTK4 Craniosynostosis Phosphorylation N Y770 P22607 2261 FGFR3 JTK4 Craniosynostosis Phosphorylation N S771 P26367 5080 PAX6 AN2 Aniridia Phosphorylation N S54 P26367 5080 PAX6 AN2 Anterior segment dysgenesis Phosphorylation N S54 P26367 5080 PAX6 AN2 Aniridia Ubiquitination N K55 P26367 5080 PAX6 AN2 Aniridia Ubiquitination N K55 P26367 5080 PAX6 AN2 Anophthalmia and microphthalmia Ubiquitination N K55 P26367 5080 PAX6 AN2 Anterior segment dysgenesis Ubiquitination N K55 P26367 5080 PAX6 AN2 Aniridia SUMOylation N K75 P26367 5080 PAX6 AN2 Aniridia Phosphorylation C S216 P26367 5080 PAX6 AN2 Aniridia Phosphorylation N S216 P26367 5080 PAX6 AN2 Lung adenocarcinoma Phosphorylation N S216 P26367 5080 PAX6 AN2 Uterine corpus endometrial carcinoma Phosphorylation N S216 P26367 5080 PAX6 AN2 Hepatocellular carcinoma Phosphorylation N T281 P26367 5080 PAX6 AN2 Skin cutaneous melanoma Phosphorylation N T303 P26367 5080 PAX6 AN2 Aniridia Phosphorylation N T373 Q6UXD5 26470 SEZ6L2 PSK UNQ1903/PRO4349 Anophthalmia and microphthalmia O-linked glycosylation N T104 Q6UXD5 26470 SEZ6L2 PSK UNQ1903/PRO4349 Anophthalmia and microphthalmia O-linked glycosylation N T105 Q6UXD5 26470 SEZ6L2 PSK UNQ1903/PRO4349 Anophthalmia and microphthalmia O-linked glycosylation N T108 Q6UXD5 26470 SEZ6L2 PSK UNQ1903/PRO4349 Pancreatic adenocarcinoma O-linked glycosylation N T108 Q6UXD5 26470 SEZ6L2 PSK UNQ1903/PRO4349 Bladder urothelial carcinoma Ubiquitination N K873 Q6UXD5 26470 SEZ6L2 PSK UNQ1903/PRO4349 Lung squamous cell carcinoma Ubiquitination N K873 Q6UXD5 26470 SEZ6L2 PSK UNQ1903/PRO4349 Skin cutaneous melanoma Ubiquitination N K873 Q6UXD5 26470 SEZ6L2 PSK UNQ1903/PRO4349 Bladder urothelial carcinoma Phosphorylation N S883 Q6UXD5 26470 SEZ6L2 PSK UNQ1903/PRO4349 Lung squamous cell carcinoma Phosphorylation N S883 Q6UXD5 26470 SEZ6L2 PSK UNQ1903/PRO4349 Skin cutaneous melanoma Phosphorylation N S883 Q6UXD5 26470 SEZ6L2 PSK UNQ1903/PRO4349 Lung squamous cell carcinoma Phosphorylation N Y884 Q6UXD5 26470 SEZ6L2 PSK UNQ1903/PRO4349 Skin cutaneous melanoma Phosphorylation N Y884 Q6UXD5 26470 SEZ6L2 PSK UNQ1903/PRO4349 Lung squamous cell carcinoma Phosphorylation N S885 Q6UXD5 26470 SEZ6L2 PSK UNQ1903/PRO4349 Skin cutaneous melanoma Phosphorylation N S885 Q6UXD5 26470 SEZ6L2 PSK UNQ1903/PRO4349 Breast adenocarcinoma Phosphorylation N Y898 Q6UXD5 26470 SEZ6L2 PSK UNQ1903/PRO4349 Breast adenocarcinoma Phosphorylation N Y906 Q9BX79 64220 STRA6 PP14296 UNQ3126/PRO10282/PRO19578 Microphthalmia Phosphorylation N S89 Q9BX79 64220 STRA6 PP14296 UNQ3126/PRO10282/PRO19578 Microphthalmia syndromic Phosphorylation N S89 Q9BX79 64220 STRA6 PP14296 UNQ3126/PRO10282/PRO19578 Stomach adenocarcinoma Phosphorylation N S89 Q9BX79 64220 STRA6 PP14296 UNQ3126/PRO10282/PRO19578 Hepatocellular carcinoma Phosphorylation N S247 Q9BX79 64220 STRA6 PP14296 UNQ3126/PRO10282/PRO19578 Skin cutaneous melanoma Phosphorylation N S247 Q9BX79 64220 STRA6 PP14296 UNQ3126/PRO10282/PRO19578 Hepatocellular carcinoma Phosphorylation N Y250 Q9BX79 64220 STRA6 PP14296 UNQ3126/PRO10282/PRO19578 Skin cutaneous melanoma Phosphorylation N Y250 Q9BX79 64220 STRA6 PP14296 UNQ3126/PRO10282/PRO19578 Skin cutaneous melanoma Phosphorylation N S404 Q9BX79 64220 STRA6 PP14296 UNQ3126/PRO10282/PRO19578 Skin cutaneous melanoma Phosphorylation N S409 Q9BX79 64220 STRA6 PP14296 UNQ3126/PRO10282/PRO19578 Hepatocellular carcinoma Phosphorylation N Y564 Q9BX79 64220 STRA6 PP14296 UNQ3126/PRO10282/PRO19578 Microphthalmia syndromic Phosphorylation N Y564 Q9BX79 64220 STRA6 PP14296 UNQ3126/PRO10282/PRO19578 Hepatocellular carcinoma Phosphorylation N T565 Q9BX79 64220 STRA6 PP14296 UNQ3126/PRO10282/PRO19578 Microphthalmia syndromic Phosphorylation N T565 Q9BX79 64220 STRA6 PP14296 UNQ3126/PRO10282/PRO19578 Colon adenocarcinoma Phosphorylation N S605 Q9BX79 64220 STRA6 PP14296 UNQ3126/PRO10282/PRO19578 Skin cutaneous melanoma Phosphorylation N S605 Q9BX79 64220 STRA6 PP14296 UNQ3126/PRO10282/PRO19578 Microphthalmia syndromic Ubiquitination N K621 Q9BX79 64220 STRA6 PP14296 UNQ3126/PRO10282/PRO19578 Skin cutaneous melanoma Ubiquitination N K621 Q9BX79 64220 STRA6 PP14296 UNQ3126/PRO10282/PRO19578 Anophthalmia and microphthalmia Phosphorylation N Y643 Q9BX79 64220 STRA6 PP14296 UNQ3126/PRO10282/PRO19578 Blastoma Phosphorylation N Y643 Q9BX79 64220 STRA6 PP14296 UNQ3126/PRO10282/PRO19578 Breast invasive carcinoma Phosphorylation N Y643 Q9BX79 64220 STRA6 PP14296 UNQ3126/PRO10282/PRO19578 Liver cancer Phosphorylation N Y643 Q9BX79 64220 STRA6 PP14296 UNQ3126/PRO10282/PRO19578 Microphthalmia syndromic Phosphorylation N Y643 P26367 5080 PAX6 AN2 Gastric cancer Methylation U 24513424